Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Assets (2022 - 2025)

Historic Assets for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $208.8 million.

  • Gossamer Bio's Assets fell 4048.66% to $208.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.8 million, marking a year-over-year decrease of 4048.66%. This contributed to the annual value of $315.3 million for FY2024, which is 108.23% up from last year.
  • As of Q3 2025, Gossamer Bio's Assets stood at $208.8 million, which was down 4048.66% from $240.9 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Assets high stood at $373.4 million for Q2 2024, and its period low was $181.7 million during Q2 2023.
  • Over the past 4 years, Gossamer Bio's median Assets value was $280.6 million (recorded in 2025), while the average stood at $281.8 million.
  • Per our database at Business Quant, Gossamer Bio's Assets surged by 10547.8% in 2024 and then crashed by 4048.66% in 2025.
  • Quarter analysis of 4 years shows Gossamer Bio's Assets stood at $272.4 million in 2022, then grew by 14.49% to $311.9 million in 2023, then increased by 1.08% to $315.3 million in 2024, then plummeted by 33.77% to $208.8 million in 2025.
  • Its Assets stands at $208.8 million for Q3 2025, versus $240.9 million for Q2 2025 and $280.6 million for Q1 2025.